Liberum Capital Reiterates “Buy” Rating for Plant Health Care plc (PHC)
Plant Health Care plc (LON:PHC)‘s stock had its “buy” rating reissued by equities researchers at Liberum Capital in a research note issued to investors on Wednesday. They presently have a GBX 45 ($0.60) price objective on the stock. Liberum Capital’s target price would suggest a potential upside of 118.18% from the stock’s current price.
Plant Health Care plc (LON:PHC) traded up 0.000% on Wednesday, hitting GBX 20.625. 68,108 shares of the stock traded hands. The firm’s 50-day moving average price is GBX 21.05 and its 200-day moving average price is GBX 40.37. The stock’s market cap is GBX 15.15 million. Plant Health Care plc has a 12-month low of GBX 14.63 and a 12-month high of GBX 97.50.
In other news, insider Ede-Golightly,James bought 150,000 shares of the business’s stock in a transaction that occurred on Friday, August 19th. The stock was purchased at an average price of GBX 10 ($0.13) per share, with a total value of £15,000 ($19,978.69).
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/17/liberum-capital-reiterates-buy-rating-for-plant-health-care-plc-phc.html
Plant Health Care plc Company Profile
Plant Health Care plc provides agricultural biological products and technology solutions. The Company’s segments include Americas, Mexico, Rest of World and New Technology. The Company focuses on businesses, including New Technology and Commercial. Its Commercial business is focused on the sale of biological products.
Receive News & Ratings for Plant Health Care plc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Plant Health Care plc and related companies with MarketBeat.com’s FREE daily email newsletter.